Access BayerPRO

<p>Stay up to date with exclusive content for Healthcare Professionals:</p><ul><li>Latest updates</li><li>Find useful tools for your practice</li><li>Access patient support materials</li></ul>

Sign up to BayerMED:

Register | Login For Further Access

404 Page

Default

You Are About To Leave The Current Site

Training

Training Title

Learning Materials

Medical Literature 

Chronic Kidney Disease 

Awareness​

Menopause

Clinical Tools 

Contraception

Women's Health

Medical Literature

Prostate Cancer

Heart Failure 

Oncology

Cardio Renal 

Ophthalmology

Bayer Logo

Womens Health.png

Plain Blue Hero Banner.png

Other

small_Cardiovascular_32px.png

Heart Failure

small_Ophthalmology_32px.png

Survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination deficiencies (HRD) treated with radium 223: Princess Margaret Cancer Centre (PMCC) experience

media:remote_media:72a9c8d8-dbf5-4d08-ae5e-48472bb226b5

Survival Outcomes for Men with mCRPC with and without HRD Treated with Radium-223: PMCC Experience

Ask a Question